Organization · Venture Capital
Vital Venture Capital
Vital Venture Capital is an early to mid-stage venture capital firm based in Simsbury, Connecticut, focusing on investments in B2B SaaS, healthcare, medical devices, diagnostics, and hardware/software sectors.
Overview
What Vital Venture Capital does
What Vital Venture Capital is
Vital Venture Capital is an early to mid-stage venture capital firm based in Simsbury, Connecticut, focusing on investments in B2B SaaS, healthcare, medical devices, diagnostics, and hardware/software sectors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2007
- Approximate age
- About 19 years
- Structured capabilities
- Funder
- Last reviewed
- April 10, 2026
Official channels
Find Vital Venture Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Vital Venture Capital as a funder
Investment thesis
Vital Venture Capital focuses on early to mid-stage investments in B2B SaaS, healthcare, medical devices, and diagnostics, aiming to provide above-market returns.
Focus narrative
Vital Venture Capital invests in business-to-business SaaS software, medical devices, diagnostics, and unique intellectual property situations. The firm typically targets investments ranging from $1-3 million across 1-3 capital rounds, preferring to invest in businesses where they can leverage their experience and contacts to add value.
Value beyond capital
Vital Venture Capital adds value through its extensive experience and network, focusing on earlier-stage companies with strong management and significant market potential.
Terms and economics
- Typical check
- $1,000,000–$3,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B
- Sectors
- SaaS · Healthcare · Biotech · Medical Devices · Diagnostics
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
- Recorded notable exits
- 10X Genomics, Ginkgo Bioworks, and Twist Bioscience
Portfolio context
Notable portfolio companies include 10X Genomics, Inc. (single cell sequencing), AxioMx, Inc. (antibody development platform), Booker Software, Inc. (enterprise management solutions), CD Diagnostics, Inc. (joint diagnostics), and Ginkgo Bioworks (organism design).
Common questions
What to know about Vital Venture Capital
Upseed classifies Vital Venture Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.